482 related articles for article (PubMed ID: 30918424)
21. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Pant V; Sen IB; Soin AS
Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
Kim YI; Paeng JC; Cheon GJ; Suh KS; Lee DS; Chung JK; Kang KW
J Nucl Med; 2016 Jul; 57(7):1045-51. PubMed ID: 26985057
[TBL] [Abstract][Full Text] [Related]
23. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
He YX; Guo QY
Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
[TBL] [Abstract][Full Text] [Related]
25. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Lee JW; Paeng JC; Kang KW; Kwon HW; Suh KS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
[TBL] [Abstract][Full Text] [Related]
26. Role of [
Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
[TBL] [Abstract][Full Text] [Related]
27. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Yoh T; Seo S; Ogiso S; Kawai T; Okuda Y; Ishii T; Taura K; Higashi T; Nakamoto Y; Hatano E; Kaido T; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):542-549. PubMed ID: 29168098
[TBL] [Abstract][Full Text] [Related]
28. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lee M; Ko H; Yun M
Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
[TBL] [Abstract][Full Text] [Related]
29. [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Asman Y; Evenson AR; Even-Sapir E; Shibolet O
Liver Transpl; 2015 May; 21(5):572-80. PubMed ID: 25644857
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
[TBL] [Abstract][Full Text] [Related]
31. Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Hyun SH; Eo JS; Song BI; Lee JW; Na SJ; Hong IK; Oh JK; Chung YA; Kim TS; Yun M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):720-726. PubMed ID: 29167923
[TBL] [Abstract][Full Text] [Related]
32. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
[TBL] [Abstract][Full Text] [Related]
35. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
[TBL] [Abstract][Full Text] [Related]
36. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
37. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Shin DY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Cancer Chemother Pharmacol; 2011 Jul; 68(1):165-75. PubMed ID: 20872146
[TBL] [Abstract][Full Text] [Related]
39. The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.
Ahn SG; Kim SH; Jeon TJ; Cho HJ; Choi SB; Yun MJ; Lee JD; Kim KS
J Gastrointest Surg; 2011 Nov; 15(11):2044-52. PubMed ID: 21904962
[TBL] [Abstract][Full Text] [Related]
40. Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?
Cho Y; Lee DH; Lee YB; Lee M; Yoo JJ; Choi WM; Cho YY; Paeng JC; Kang KW; Chung JK; Yu SJ; Lee JH; Yoon JH; Lee HS; Kim YJ
PLoS One; 2014; 9(8):e105679. PubMed ID: 25153834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]